Technology
Health
Pharmaceutical

Acasti Pharma

$1.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.21 (15.33%) Today
-$0.03 (-1.90%) As of 7:26 PM EDT after-hours

Why Robinhood?

You can buy or sell Acasti Pharma and other stocks, options, ETFs, and crypto commission-free!

About ACST

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. Read More The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Employees
Headquarters
Laval, Québec
Founded
2002
Market Cap
107.04M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.12M
High Today
$1.59
Low Today
$1.43
Open Price
$1.47
Volume
5.07M
52 Week High
$1.80
52 Week Low
$0.4333

Collections

Technology
Health
Pharmaceutical
2013 IPO
Canada
North America
Female CEOs

ACST Earnings

-$0.47
-$0.33
-$0.19
-$0.05
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
-$0.16 per share
Actual
Expected Aug 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.